Key Record Dates
ClinicalTrials.gov Identifier: | NCT04619680 |
---|---|
Brief Title: | The Study Will Evaluate the Use of Nintedanib in Slowing Lung Fibrosis in Patients With Pulmonary Infiltrates Related to COVID-19 (ENDCOV-I) |
First Submitted : | November 5, 2020 |
First Submitted that Met QC Criteria : | November 5, 2020 |
First Posted : | November 6, 2020 |
Last Update Submitted that Met QC Criteria : | December 15, 2020 |
Last Update Posted : | December 17, 2020 |